CVS Group plc, a leading provider of integrated veterinary services in the UK, has confirmed that no employees exercised options under the CVS Group SAYE Plans in April. As a result, the company's total issued share capital remains at 71,721,269 Ordinary Shares, each carrying one voting right, with no Ordinary Shares held in treasury. This figure will be used by shareholders as the denominator for the calculations to determine if they are required to notify their interest or a change to their interest in the company under the FCA's Disclosure Guidance and Transparency Rules.
The company's leadership team includes Richard Fairman, CEO, and Scott Morrison, Company Secretary. CVS Group plc is listed on AIM and is supported by Peel Hunt LLP as the Nominated Adviser & Broker and Berenberg as the Joint Broker. Camarco provides financial PR for the company.
CVS Group plc operates approximately 500 veterinary practices across the UK, Australia, the Netherlands, and the Republic of Ireland, including specialist referral hospitals and dedicated out-of-hours sites. In addition to the Veterinary Practices division, the company also operates Laboratories, providing diagnostic services, Crematoria for pet cremation and clinical waste disposal, and the online retail business, "Animed Direct."
The company's focus is on providing high-quality clinical services to its clients and their animals, with dedicated clinical teams and support colleagues at the core of its strategy. CVS Group plc is committed to delivering outstanding veterinary care and services to its customers across its various territories.